Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp lessened its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 1.6% during the 2nd quarter, Holdings Channel reports. The firm owned 745,502 shares of the health services provider’s stock after selling 11,968 shares during the quarter. Mackenzie Financial Corp’s holdings in Amedisys were worth $68,437,000 as of its most recent filing with the SEC.

A number of other hedge funds have also modified their holdings of the company. Squarepoint Ops LLC boosted its position in Amedisys by 72.8% in the second quarter. Squarepoint Ops LLC now owns 64,947 shares of the health services provider’s stock valued at $5,962,000 after buying an additional 27,353 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of Amedisys by 146.4% in the 2nd quarter. Bank of Montreal Can now owns 10,429 shares of the health services provider’s stock valued at $966,000 after acquiring an additional 6,197 shares during the last quarter. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of Amedisys by 43.7% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 26,286 shares of the health services provider’s stock valued at $2,414,000 after acquiring an additional 8,000 shares during the last quarter. Canada Pension Plan Investment Board increased its stake in shares of Amedisys by 61.0% in the second quarter. Canada Pension Plan Investment Board now owns 79,200 shares of the health services provider’s stock worth $7,271,000 after acquiring an additional 30,000 shares during the period. Finally, Intech Investment Management LLC acquired a new position in Amedisys during the second quarter valued at $280,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on AMED shares. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target for the company. in a research report on Monday, July 29th. Finally, William Blair lowered Amedisys from an “outperform” rating to a “market perform” rating in a research report on Monday, July 1st. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $100.67.

Amedisys Price Performance

NASDAQ:AMED opened at $96.63 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. Amedisys, Inc. has a 52 week low of $89.55 and a 52 week high of $98.95. The stock’s 50-day moving average price is $97.61 and its 200-day moving average price is $94.95. The stock has a market capitalization of $3.16 billion, a PE ratio of -150.98, a price-to-earnings-growth ratio of 1.90 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.10. The firm had revenue of $591.19 million for the quarter, compared to analyst estimates of $579.34 million. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. As a group, equities analysts expect that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.